Lux Venture Partners V, LLC
SEC Form 4 insider trading activity
Lux Venture Partners V, LLC has filed 1 SEC Form 4 filing (5 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Feb 6, 2026.
On the most recent filing, Lux Venture Partners V, LLC is listed as 10% Owner at Eikon Therapeutics, Inc. Inside the rolling window, Lux Venture Partners V, LLC reported 1 open-market purchase totaling $2.5M in EIKN and no open-market sales.
Companies traded
Other insiders at EIKN
Insider Buying
$2.5M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Lux Venture Partners V, LLC made?
Lux Venture Partners V, LLC has filed 1 SEC Form 4 filing (5 transaction rows) across 1 company since 2026.
Which companies does Lux Venture Partners V, LLC trade?
Lux Venture Partners V, LLC has filed SEC Form 4 disclosures for 1 company, including EIKN.
When was Lux Venture Partners V, LLC's most recent SEC Form 4 filing?
Lux Venture Partners V, LLC's most recent SEC Form 4 filing on Tracefour is dated Feb 6, 2026.
What is Lux Venture Partners V, LLC's total buy and sell value in the current window?
Inside the rolling retention window, Lux Venture Partners V, LLC bought $2.5M and sold $0 based on SEC Form 4 filings.
What was Lux Venture Partners V, LLC's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 138,888 EIKN shares on 2026-02-04, worth $2.5M, per SEC Form 4 filings.